Simulation accelerates drug development by reducing scale-up risk, improving process insight and enabling faster decisions with AI and Digital Twin technology.
This blog explains how pharmaceutical organizations can use an integrated digital thread to reduce drug development timelines, fully leveraging AI capabilities while maintaining regulatory compliance throughout the drug discovery…
The pressures in pharma manufacturing Pharma manufacturing is not for the faint of heart. Stringent regulations, zero tolerance for errors…
The pharmaceutical industry faces immense pressure to accelerate innovation, mitigate development risks and maximize research and development (R&D) returns at scale. While advanced…
Over the past couple of decades, an increasing number of IT systems are being used to define and document the research and development phases of pharmaceutical products. This comes at a time when the pharma industry is searching for much-needed productivity gains in the R&D processes.
Learn more about the simulation process and read how health care companies used simulation to improve patient lives.
“regulatory expectations continue to track towards greater control, visibility, accountability, and traceability”
